Silymarin inhibits the lipogenic pathway and reduces worsening of non-alcoholic fatty liver disease (NAFLD) in mice.
Carvalho LCF, Ferreira FM, Dias BV, Azevedo DC, de Souza GHB, Milagre MM, de Lana M, Vieira PMA, Carneiro CM, Paula-Gomes S, Cangussu SD, Costa DC.
Carvalho LCF, et al. Among authors: milagre mm.
Arch Physiol Biochem. 2022 Nov 3:1-15. doi: 10.1080/13813455.2022.2138445. Online ahead of print.
Arch Physiol Biochem. 2022.
PMID: 36328030